BioRestorative Therapies, Inc. announced that it has entered into a definitive agreement with several accredited and institutional investors for the sale of 685,033 shares at an offering price of $3.03 per share for the gross proceeds of $2.07565 million before deducting placement agent fees and other estimated offering expenses on July 11, 2023. The shares in the offering are being offered by the company pursuant to a shelf registration statement on Form S-3 previously filed with the U.S. Securities and Exchange Commission and declared effective by the SEC on February 14, 2023.The transaction is expected to close on or about July 13, 2023, subject to the satisfaction of customary closing conditions.